Cubist Systematic Strategies, LLC Novo Nordisk A S Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $3.93 Million - $5.23 Million	-38,486 Reduced 15.09%	216,596 $27.8 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $22.4 Million - $26.9 Million	255,082 New	255,082 $26.4 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $2.84 Million - $3.14 Million	18,216 Added 97.64%	36,873 $5.97 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $3.5 Million - $4.21 Million	-26,453 Reduced 58.64%	18,657 $2.97 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $3,281 - $4,330	-32 Reduced 0.07%	45,110 $6.1 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $2.67 Million - $3.28 Million	-28,051 Reduced 38.32%	45,142 $4.5 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $2.67 Million - $3.28 Million	-28,051 Reduced 38.32%	45,142 $4.5 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $4.9 Million - $5.78 Million	47,455 Added 184.38%	73,193 $8.16 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $90,493 - $109,388	972 Added 3.92%	25,738 $2.86 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $2.4 Million - $2.93 Million	-25,035 Reduced 50.27%	24,766 $2.77 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $3.45 Million - $4.36 Million	40,909 Added 460.07%	49,801 $4.78 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $1.84 Million - $2.31 Million	-27,268 Reduced 75.41%	8,892 $745,000
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $1.33 Million - $1.5 Million	19,781 Added 120.77%	36,160 $2.44 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $606,891 - $701,026	-9,499 Reduced 36.71%	16,379 $1.14 Million
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $378,127 - $416,896	5,937 Added 29.77%	25,878 $1.8 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $123,109 - $142,877	2,103 Added 11.79%	19,941 $1.31 Million
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $260,159 - $340,742	5,260 Added 41.82%	17,838 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $627,139 - $732,794	12,578 New	12,578 $728,000
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $874,355 - $982,684	-18,392 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $516,140 - $578,796	11,031 Added 149.86%	18,392 $939,000
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $246,635 - $279,991	-5,320 Reduced 41.95%	7,361 $385,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $183,399 - $208,608	4,415 Added 53.41%	12,681 $584,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $386,518 - $423,549	8,266 New	8,266 $390,000
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $436,787 - $497,242	-9,862 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $57,412 - $68,837	-1,184 Reduced 10.72%	9,862 $486,000
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $29,421 - $33,258	-619 Reduced 5.31%	11,046 $593,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $480,014 - $574,151	11,665	11,665 $562,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.72 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.22 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.22 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.13 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.04 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account